Abstract
Cervical cancer is the second commonest cancer among women in Nigeria, with one-third of all cases occurring during the reproductive period. However, different barriers, including the unaffordability of vaccines and ineffective screening programs, delay preventive measures. Hence, the need to adequately tackle those barriers to improve uptake. Using an interviewer-administered questionnaire, the descriptive cross-sectional study design was adopted to gather data from 344 pregnant women attending antenatal clinics in three hospitals in Ibadan. Data collected were entered into the Statistical Package for Social Sciences, version 20.0. Frequency distribution tables, mean, figures, and multinomial logistics regression were used to summarize and present the data. Most Pregnant women, 34.3%, were aged between 25-29 years, with 35.8.% of them having poor knowledge of HPV, while 61.1% had poor knowledge of cervical cancer. Also, 43.3% of the participants had never heard of HPV. In addition, 47.7% of respondents stated that distance to a health facility could hinder their utilization of cervical cancer prevention strategies. The multinomial logistic regression showed a significant association between awareness of HPV Vaccination and plan for HPV vaccination aOR 0.32 CI (0.14 – 0.76), and plan for cervical cancer screening aOR 0.24 CI (0.11 – 0.53) respectively. It is crucial to correct the negative perception and attitude towards cervical cancer and its preventive measures to help to increase its adoption.
Highlights
Cervical cancer burden remains high worldwide with an estimated 578,000 cases and 266,000 deaths each year, and it is both the fourth most common cause of cancer and the fourth most common cause of death from cancer in women [1], [2]
45.9% stated they would encourage their family members to receive a pap smear, while 45.9% stated they might be willing to pay for a pap smear, with 52.9% stating they plan to do a cervical cancer screening
Findings from this study show a lack of knowledge and awareness about Human papillomavirus vaccination and cervical cancer screening among respondents
Summary
Cervical cancer burden remains high worldwide with an estimated 578,000 cases and 266,000 deaths each year, and it is both the fourth most common cause of cancer and the fourth most common cause of death from cancer in women [1], [2]. The Human Papillomavirus (HPV) infection, responsible for 90% of cervical cancer cases, has a disproportionately high burden in low-and-middle-income countries, with more than 90% of the estimated 3110,000 deaths from the disease occurring in these countries [4]-[6]. Cervical cancer is responsible for around 12% of all cancer cases and 7.5% of all cancer-related deaths in developing countries [7] These marked differences can be explained by inadequate access to screening services that facilitate early detection and treatment, low preventive health behavior, and lack of access to effective screening services [8], [9]. The risk of HPV infection is higher during pregnancy owing to hormonal changes and immunosuppression [12]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
